Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05256927 · ClinicalTrials.gov registry record
Is Milk Associated with Glycemia in the NICU
A clinical trial, sponsored by University of Rochester.
- Completed
- Registry status
- 124
- Enrollment target
NCT05256927 is a clinical trial that has completed, run by University of Rochester. The registered enrollment target is 124 participants.
The verdict
NCT05256927 has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 124 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if concentrations of hormones in prepared human milk (HM) feeds are associated with metabolic disturbances in the recipient premature infant. To do so, prospectively 100 infants receiving HM-derived fortifiers as part of clinical care will be studied, saving aliquots of daily prepared feeds until any fortification ceases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2022-02-16 |
| Est. Completion | 2024-03-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05256927
The ClinicalTrials.gov registry entry for NCT05256927 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05256927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05256927 about?
NCT05256927 is a clinical study titled "Is Milk Associated with Glycemia in the NICU". The purpose of this study is to determine if concentrations of hormones in prepared human milk (HM) feeds are associated with metabolic disturbances in the recipient premature infant. To do so, prospectively 100 infants receiving HM-derived fortifiers as part of clinical care will be studied, saving...
What is the current status of trial NCT05256927?
This trial is currently completed. The enrollment target is 124 participants. The study started on 2022-02-16. Estimated completion is 2024-03-10.
Who is sponsoring clinical trial NCT05256927?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.